Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Free Cash Flow Generation Index

Latest as of December 2023: -0.89x

Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Free Cash Flow Generation Index of -0.89x as of December 2023. Free cash flow of CN¥-33.12 Million represents -1% of operating cash flow (CN¥37.03 Million). See 301281 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-0.89x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-33.12 Million
CNY

Operating Cash Flow

CN¥37.03 Million
CNY

Capital Expenditures

CN¥70.15 Million
CNY

Shandong Keyuan Pharmaceutical Co. Ltd. A Free Cash Flow Generation Index (2021–2023)

Historical FCF Generation Index trend for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. Explore Shandong Keyuan Pharmaceutical Co. Ltd. (301281) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)

Year-by-year Free Cash Flow Generation Index for Shandong Keyuan Pharmaceutical Co. Ltd. A. For the full company profile including market capitalisation, see Shandong Keyuan Pharmaceutical Co. Ltd. market cap and net worth.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2023 -0.89x CN¥-33.12 Million CN¥37.03 Million CN¥70.15 Million ▼ -222.3%
2022 0.73x CN¥84.75 Million CN¥115.86 Million CN¥31.11 Million ▲ +19.6%
2021 0.61x CN¥31.83 Million CN¥52.02 Million CN¥20.19 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).